Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience

OBJECTIVES: To assess the efficacy and safety profile of tofacitinib taken orally at a dose of 10 mg/day in patients with severe active rheumatoid arthritis (RA). MATERIAL AND METHODS: The retrospective observational study included 10 patients (6 women and 4 men) with RA treated with tofacitinib. Al...

Descripción completa

Detalles Bibliográficos
Autores principales: Madej, Marta, Woytala, Patryk, Frankowski, Marek, Lubiński, Łukasz, Sokolik, Renata, Sebastian, Agata, Maciążek-Chyra, Beata, Wiland, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753599/
https://www.ncbi.nlm.nih.gov/pubmed/31548745
http://dx.doi.org/10.5114/reum.2019.87609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753599/
https://www.ncbi.nlm.nih.gov/pubmed/31548745
http://dx.doi.org/10.5114/reum.2019.87609

Ejemplares similares